clinical entity among nephrotic syndromes [1] . It is an from different mutations in Finnish patients. autosomal recessive disorder with an incidence of 1:8200
nutritional support, followed by bilateral nephrectomy within days after birth regardless of the genotype detected. No and dialysis, and finally, by renal transplantation [6] . difference could be found in neonatal, renal, cardiac, or neuro-The gene for NPHS1 (NPHS1 gene) has been localized logical features in patients with different mutations. Nephrin to chromosome 19q13. 1 [7, 8] and was recently identified was not expressed in kidneys with Fin-major or Fin-minor mutations, while another slit diaphragm-associated protein,  as a novel 29-exon gene [9] . The protein product of this stained normally. In electron microscopy, podocyte fusion and gene was termed nephrin. It is a transmembrane protein podocyte filtration slits of various sizes were detected. The of the immunoglobulin superfamily containing 1241 amino slit diaphragms, however, were missing. In contrast to this, a acids. Nephrin is produced by glomerular podocytes, and nephrotic infant with Fin-major/R743C genotype expressed nephrin in kidney had normal slit diaphragms and responded recently, we localized nephrin at the slit diaphragm of to therapy with an angiotensin-converting enzyme inhibitor the glomerular podocytes, suggesting that this structure and indomethacin. and nephrin play an essential role in the normal glomeru-Conclusions. The most common NPHS1 gene mutations, Fin-major and Fin-minor, both lead to an absence of nephrin lar filtration process [10] . and podocyte slit diaphragms, as well as a clinically severe form
The two most common mutations in the NPHS1 gene of NPHS1, the Finnish type of congenital nephrotic syndrome.
have been named Fin-major and Fin-minor and are highly enriched in the Finnish population [9] . Sixty-five percent of the Finnish patients were homozygous for the Congenital nephrotic syndromes (CNS) form a heter-Fin-major mutation, and 8% were homozygous for Finogenous group of diseases characterized by proteinuria minor. Sixteen percent of the patients were compound shortly after birth [1] . NPHS1 (MIM 256300) is a distinct heterozygous. Eight percent of the patients were Finmajor heterozygotes with missense mutations in the other
In non-Finnish patients, a great variety of mutations have been described recently, including insertions, deletions, and nonsense and missense mutations [11] . These mutations were scattered along the entire NPHS1 gene. The clinical features of NPHS1 children were thoroughly studied in the early 1970s [5] . Since then, the diagnostic methods and the management of these children have changed dramatically. This and the discovery of the genetic basis of this disease prompted us to perform a systematic analysis of the clinical manifestations and renal pathology of the Finnish NPHS1 patients. This seemed especially interesting since the two most common mutations, Fin-major and Fin-minor, affect the opposite ends of the nephrin molecule.
METHODS

Genetic analysis
The identification of the NPHS1 gene and an analysis of the mutations of NPHS1 children have been described [9] . The total of 46 patients studied included 29 patients homozygous for the Fin-major mutation, 4 patients homozygous for the Fin-minor mutation, and 8 compound heterozygotes for these mutations. Three patients had a Fin-major mutation in one and an identified missense mutation in the other gene. One patient had a Fin-major mutation in one gene and probably a splice mutation in the other gene. Finally, one patient had three missense mutations ( Fig. 1 ). The treatment of children with NPHS1 occurred in gene. Fin-major mutation is a 2 bp deletion in exon 2, and Fin-minor three stages, as has been described earlier [1] . Briefly, mutation is a nonsense mutation in exon 26. The three missense mutaafter nephrosis was diagnosed, the patients were suppletions are also indicated. (B) Nephrin molecule. Fin-major mutation leads to a truncated protein of 90 amino acids and Fin-minor to a mented with daily albumin infusions and a high-calorie truncated protein of 1109 amino acids. W64S is a change of tryptophan diet. The medication included thyroxin, sodium warfarin, to serine in Ig-1. C465T is a change of cysteine to tyrosine in Ig-5, and and prompt antibiotic therapy for septic infections. Bi-R743C is a change of arginine to cysteine in Ig-7. (C) Genotypes of the Finnish NPHS1 patients included in this study. lateral nephrectomy was performed when the children weighed about 7 kg and peritoneal dialysis was started. Renal transplantation either from a parent or from a cadaver donor was done when the patient weighed at Light and electron microscopy of kidney samples least 9 kg [12] .
Patient management
Histologic slides of the nephrectomized kidneys be-Collection of clinical data tween the years 1986 and 1998 were collected and reexamined. Forty-four cases were obtained. The ages of The clinical symptoms and signs as well as laboratory the patients at nephrectomy ranged from 4 months to values during the nephrotic stage were analyzed retro-3.7 years, most of the nephrectomies (36 out of 44) being spectively. These included birth weight and height, plaperformed between 6 and 18 months. Abnormalities of cental weight, gestational age, the time of recognition of glomeruli, tubuli, and blood vessels and interstitial fithe disease, blood, and urine biochemistry. The amount brosis and inflammation were recorded. The number of of protein loss was evaluated by recording urine protein obsolescent glomeruli, extension of tubular microcysts, measurements and the albumin substitution required at interstitial fibrosis, and inflammation were arbitrarily the age of three to six months. Neurological status, findgraded from nil to 3ϩ. The histology score was obtained ings on electroencephalography (EEG), and computed by adding these together ( Table 2) . tomography (CT) of the brain were recorded. The results of cardiac examinations were analyzed.
Electron microscopy was performed according to stan- a Results are given as means and range b These included three patients with Fin-major in one gene and missense mutation in the other gene, one patient with three missense mutations, and one patient with Fin-major mutation in one gene and a probable splice mutation in the other gene ( Fig. 1 (San Francisco, CA, USA). cohol, the samples were embedded in epoxy resin for thin sectioning and electron microscopy. The samples came Western blotting for nephrin was performed on glomerular extracts obtained from four nephrectomized kidneys. from two patients homozygous for the Fin-major mutation, two patients who were compound heterozygous for Glomerular sieving was performed as previously described [14] . The samples came from two patients homozygous the Fin-major and Fin-minor mutations, and one patient with Fin-major mutation in one chromosome and a mis-for the Fin-major mutation and two patients with compound heterozygotes for Fin-major and Fin-minor muta-sense mutation R743C in the other chromosome ( Fig. 1 ).
tions. Ten micrograms of Triton X-100-soluble protein Expression of nephrin in NPHS1 kidneys were separated on 4 to 20% gradient gel and transferred into polyvinyl difluoride membrane. Membrane was blot-In situ hybridization for nephrin mRNA was performed ted with monoclonal antibody reacting against the extraas previously described [13] . Briefly, tissue sections were cellular part of nephrin (Ruotsalainen et al, manuscript incubated with 1.2 ϫ 10 6 33 P-labeled (1000 Ci/mmol; Amin preparation), and mouse IgG was detected with alkaline ersham, Arlington Heights, IL, USA) antisense and sense phosphatase-conjugated anti-mouse IgG (Dako Corporariboprobes in a total volume of 80 L. The probes were tion, Carpinteria, CA, USA) and 5-bromo-4-chloro-3synthesized by subcloning a cDNA fragment of 287 bp indoyl phosphate p-toluidine salt and p-nitro blue teracorresponding to exon 10 in human NPHS1 gene into zolium chloride. pBluescript and antisense and sense RNAs produced using T3 and T7 RNA polymerases, respectively. Parafor-Statistics maldehyde-fixed cryosections came from two patients homozygous for the Fin-major mutation, two patients ho-Statistical analyses were carried out using the Student's t-test. mozygous for the Fin-minor mutation, and two patients who were compound heterozygous for these mutations.
Immunofluorescence studies of nephrin in nephrecto-RESULTS mized kidneys and in one kidney biopsy were performed Neonatal and nonrenal features in a standard fashion. Paraformaldehyde-fixed cryosections were used. The tissue samples came from four patients
The majority (38 out of 46, 83%) of NPHS1 children homozygous for Fin-major mutation, one patient homowere born prematurely (Ͻ38th week) with a birth weight zygous for Fin-minor mutation, and three patients who ranging from 1450 to 3480 g. Only two newborns were were compound heterozygous for these. One sample came small for their gestational age. Amniotic fluid was often meconium stained, but a great majority of the neonates from a child with Fin-major mutation in one chromosome and R743C missense mutation in the other (Fig. 5 ). Two did not have pulmonary problems. The index of placental weight/birth weight (ISP) was over 25% in all except polyclonal rabbit anti-nephrin antisera were available. One was directed against the extracellular [10] and the one newborn with Fin-major/Fin-major mutations. No major differences were observed in the neonatal findings patients with different mutations. In 82% of the infants, nephrotic syndrome was diagnosed within the first week between the different genotypes (Table 1) .
Infants with NPHS1 did not have any major nonrenal after birth ( Table 2 ). The diagnosis was delayed from two weeks to two months in seven infants homozygous malformations. On the other hand, minor functional disorders in central nervous system and heart were quite for the Fin-major mutation (including two pairs of twins).
No difference in the rate of hematuria between patients common during the nephrotic stage. Most of the children had muscular hypotonia regardless of the mutation (Ta-with different mutations could be found. Also, no difference in the amount of intravenous albumin substitution ble 1). EEG was performed to 41 infants at the age of needed to maintain serum albumin over 15 g/L was de-6 to 12 months. The finding was normal in 28 (68%) cases.
tected. All patients had normal creatinine values during Mild or moderate background activity was recorded in the first months. Five patients with Fin-major and Finnine patients and focal activity in four patients (Table 1) .
minor mutations received angiotensin-converting enzyme Either CT or magnetic resonance imaging (MRI) or both (ACE) inhibitor therapy without a need for a reduction were performed on 41 patients at the age of 6 to 12 of proteinuria or albumin substitution. months. Over one third (12 out of 26) of patients homo-
The kidneys were nephrectomized when the infants zygous for Fin-major mutation, four out of seven comweighed over 7 kg. In histopathological examination, pound heterozygotes, and one Fin-minor homozygote glomeruli showed mesangial hypercellularity, hyperlohad mild atrophic changes. bulated capillary tufts, and some scarring. Also, micro-During the nephrotic stage, many children had mild carcystic dilation of both proximal and distal tubuli as well as diac hypertrophy, as shown by x-ray films. Cardiac evaluinterstitial fibrosis and inflammation could be observed ation, including ultrasound examination, was performed ( Table 2) . No major differences were found between in 42 patients during the nephrotic stage. Minor disordifferent genotypes. ders, including cardiac hypertrophy, mild pulmonary stenosis, and atrial septal defect, were observed, but there Nephrin and the slit diaphragm in NPHS1 kidneys was no accumulation of any of these defects in any pa-In situ hybridization for nephrin mRNA showed quite tient groups (Table 1) . normal signal in nephrectomized NPHS1 kidneys with
Renal findings
Fin-major or Fin-minor mutations (Fig. 2) . However, immunofluorescence staining with antibodies reacting Proteinuria and low serum albumin levels were usually already found in the first samples taken after birth in against the intracellular and extracellular part of nephrin expression of nephrin, and slit diaphragms were evident in electron microscopy (Fig. 6B, C) . After taking a kidney biopsy, therapy with prednisone and cyclophosphamide was also tried, but they had no effect on the residual proteinuria. The child is now 2.5 years old with only mild proteinuria (Ͻ1 g/L).
DISCUSSION
This study shows that the two most common mutations teinuria, and full-blown nephrosis soon after birth. Also, these patients do not react to ACE inhibitors or indomethacin. remained negative in kidneys with Fin-major and Fin-As the Fin-major mutation results in a nephrin moleminor mutations (Fig. 3 ). The expression of another slit cule of only 90 amino acid residues [9], it seemed probadiaphragm protein, ZO-1, was normal ( Fig. 3) . In Westble that Fin-major homozygotes would not show immuern blot analysis, a monoclonal anti-nephrin antibody noreactivity to nephrin. Indeed, the Fin-major mutation showed no immunoreactive bands in Triton-X extracts leads to a complete absence of the protein. In contrast, of isolated glomeruli from NPHS1 kidneys with Fin-Fin-minor mutation only leads to the loss of a part (132 major and Fin-minor mutations (Fig. 4) .
terminal amino acids) of the intracellular domain of Electron microscopy of the glomeruli showed podonephrin [9] . Therefore, the protein, although multifunccyte fusions, as reported previously [15] . Irregular podotional, could be expected to be expressed and present cyte foot processes were also seen in kidneys with Finon the podocyte plasma membrane. This was, however, major and Fin-minor mutations (Fig. 5) . Filtration slits not the case, as we saw no immunoreactivity of nephrin between the foot processes were of different sizes. In in immunofluorescence staining of the kidney sections or about a quarter, the slits were extremely narrow (Ͻ20 immunoblotting of glomerular extracts. The finding that nm), and on the other hand, slits with a width of up to the Fin-minor mutation leads to an absence of nephrin 90 nm were occasionally observed. More importantly, on the podocyte surface was unexpected. no filamentous image of slit diaphragm was seen in any Nephrin has been localized to the slit diaphragm reof the 76 filtration slits analyzed in NPHS1 glomeruli with gion of glomeruli [10] . Therefore, it was of interest to Fin-major and Fin-minor mutations (Fig. 5) . In normal see how the lack of nephrin in kidneys with Fin-major kidneys, the image of slit diaphragm was seen in 52 of and Fin-minor mutations affects the ultrastructure of the the 82 podocytes slit areas (64%) studied. The width of glomerular filtration barrier. As reported previously [15] , the filtration slit also showed less variation in normal an irregular pattern and fusion of podocyte foot proglomeruli and was between 25 and 50 nm in all slit pores cesses was seen in electron microscopy. In addition, quite studied.
normal-looking podocyte slits were observed. However, no slit diaphragms were present in these slits. This sup-Findings in patients with missense mutations ports the idea that nephrin is an important component of Figure 1 lists the five patients with missense mutations slit diaphragm and plays a crucial role for the glomerular in at least one gene. Four of these were clinically indistinfiltration barrier. guishable from children with Fin-major and/or Fin-minor
The width of the slit pore in NPHS1 glomeruli showed mutations in both genes. Unfortunately, all of these four greater variation than in normal kidneys. Narrow slits were born in the early 1990s, and no renal tissue was (Ͻ20 nm) were present in NPHS1 kidneys but not in available for analysis of nephrin expression. normal glomeruli. Since the structure of the slit dia-An interesting exception to these findings was a child phragm is still largely unknown, the molecular basis for with Fin-major/R743C mutations (Fig. 6) . She was born this phenomenon remains to be seen. The zonula ocin 1997, and nephrosis was detected immediately after cludens-1-antigen (ZO-1) is a cytosolic component of birth. Proteinuria ranged from 2.8 up to 75 g/L, and ACE the slit diaphragm region in human kidney [16] , and inhibitor and indomethacin therapy was started at the recently, P-cadherin was localized to the this area [17] . age of three months. After two months of therapy, pro-
The podocyte surface is also rich of negatively charged teinuria decreased to a level of 1 to 3 g/L (Fig. 6A ). Renal glycoproteins, which have an impact on the foot process interactions. The role of these components in the ultra-biopsy was performed. The kidney glomeruli showed structural organization of the podocyte slit in normal tional areas. They did not correlate these staining patterns to the NPHS1 genotype, and the significance of their and NPHS1 glomerulus is unclear.
Interestingly, the expression of ZO-1 was normal in findings remains unclear. In our study, the negative immunofluorescence staining and immunoblotting of the NPHS1 kidneys, indicating that the lack of nephrin does affect the expression of ZO-1. This is different from glomerular extracts as well as the lack of slit diaphragm in kidneys with Fin-major and Fin-minor mutations that seen in rats. Injection of antibodies against a slit diaphragm antigen, p51, induces nephrosis in rats and strongly indicate that both mutations lead to the total lack of functional nephrin in these patients. leads to progressive decline in stainable . It was recently shown that p51 antigen is an epitope of Based on the immunohistologic and microscopic findings, it is not surprising that the clinical features of chil-nephrin molecule [19] , suggesting that nephrin and ZO-1 in this model are linked together.
dren with Fin-major and Fin-minor mutations were similar. Both mutations lead to full-blown nephrosis soon Recently, Holthö fer et al described the expression of nephrin in normal and NPHS1 kidneys using two poly-after the birth, and large amounts of albumin were needed to substitute the protein loss. Also, therapy with clonal antibodies against nephrin [20] . In immunofluorescence nephrin was not detected in NPHS1 kidneys, agents reducing the glomerular filtration pressure were not successful in diminishing the proteinuria. Previously, but in immunoelectron microscopy, they noticed some nephrin-specific gold particles at the flattened apical sur-non-Finnish CNS patients responding to ACE inhibitors and indomethacin have been published [21, 22] . face of podocytes and rarely at the intercellular junc- Enalapril and indomethacin were started at the age of three months. The dosing was gradually increased, and two months later (indomethacin 2.2 mg/kg/day and enalapril 1.3 mg/kg/day), a reduction in urinary protein from about 30 g/L to 1 to 3 g/L was observed. After this, prednisone and cyclophosphamide were given for four months and six weeks, respectively, to decrease further the protein excretion. No clear response was observed with either of the drugs. (B) Kidney biopsy was taken at the age of five months (after the decrease of proteinuria), and in immunofluorescence staining, nephrin was expressed normally in the glomeruli. (C ) In electron microscopy, fusion of foot processes as well as quite normal-looking foot processes could be seen. Filamentous images of slit diaphragms looked normal between the foot processes (arrows).
Our patient material, however, included one impor-(so-called Finnish type) or to a less severe clinical picture of CNS. Based on the present data, a renal biopsy on tant exception: a child with a Fin-major mutation in one gene and a missense mutation (a change of arginine-743 infants with congenital nephrosis who are not Fin-major or Fin-minor homozygotes or compound heterozygotes to cysteine in the extracellular Ig-5 domain) in the other one. Her nephrosis was detected immediately after birth, may be indicated. If the kidneys express nephrin and electron microscopy reveals the presence of slit dia-and proteinuria up to 75 g/L was measured during the first months. However, she responded to enalapril and phragms, a response to an ACE inhibitor and indomethacin might be expected. On the other hand, if immunoflu-indomethacin therapy and has avoided renal transplantation. The obvious explanation came from the micro-orescence staining for nephrin is negative, the chances for a response are small, and renal transplantation seems scopic studies. Her kidneys expressed nephrin, and slit diaphragms were present between the podocyte foot pro-to be the only option. The expression of nephrin in nonrenal tissues is not cesses. Thus, although the missense mutation in the NPHS1 gene led to a "functional" disorder in her glo-completely known. Northern hybridization did not reveal nephrin-RNA in fetal placenta, liver, brain, lung, merular filtration barrier, the pharmacological reduction of the glomerular filtration pressure was enough to re-muscle, or pancreas [9] . Recent findings, however, have shown that mRNA for nephrin is present in cells of the duce the protein leakage dramatically.
Recently 
